TrialJournal of clinical lipidology

Volanesorsen, an antisense oligonucleotide to apolipoprotein C-III, increases lipoprotein lipase activity and lowers triglycerides in partial lipodystrophy.

Marissa Lightbourne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.